Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.66 Million EUR | -5.28% |
| 2022 | 24.98 Million EUR | -20.63% |
| 2021 | 31.48 Million EUR | -41.36% |
| 2020 | 53.68 Million EUR | 26.31% |
| 2019 | 42.5 Million EUR | 46.27% |
| 2018 | 29.05 Million EUR | -1.3% |
| 2017 | 29.44 Million EUR | 5.36% |
| 2016 | 27.94 Million EUR | -0.0% |
| 2015 | 27.94 Million EUR | -6.42% |
| 2014 | 29.86 Million EUR | -5.18% |
| 2013 | 31.49 Million EUR | -7.1% |
| 2012 | 33.9 Million EUR | -5.8% |
| 2011 | 35.98 Million EUR | -3.15% |
| 2010 | 37.15 Million EUR | 2.73% |
| 2009 | 36.16 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 23.4 Million EUR | 0.0% |
| 2023 Q4 | 23.66 Million EUR | 0.0% |
| 2023 Q3 | 23.66 Million EUR | -7.52% |
| 2023 Q2 | 25.59 Million EUR | 0.0% |
| 2023 Q1 | 25.59 Million EUR | 2.42% |
| 2023 FY | 23.66 Million EUR | -5.28% |
| 2022 FY | 24.98 Million EUR | -20.63% |
| 2022 Q3 | 24.98 Million EUR | -15.77% |
| 2022 Q2 | 29.66 Million EUR | 0.0% |
| 2022 Q1 | 29.66 Million EUR | -5.78% |
| 2022 Q4 | 24.98 Million EUR | 0.0% |
| 2021 Q1 | 35.51 Million EUR | -33.85% |
| 2021 FY | 31.48 Million EUR | -41.36% |
| 2021 Q3 | 31.48 Million EUR | -11.35% |
| 2021 Q2 | 35.51 Million EUR | 0.0% |
| 2021 Q4 | 31.48 Million EUR | 0.0% |
| 2020 Q3 | 53.68 Million EUR | -38.74% |
| 2020 Q1 | 87.63 Million EUR | 106.19% |
| 2020 FY | 53.68 Million EUR | 26.31% |
| 2020 Q2 | 87.63 Million EUR | 0.0% |
| 2020 Q4 | 53.68 Million EUR | 0.0% |
| 2019 Q2 | 37.36 Million EUR | 0.0% |
| 2019 Q4 | 42.5 Million EUR | 12.02% |
| 2019 Q3 | 37.94 Million EUR | 1.56% |
| 2019 FY | 42.5 Million EUR | 46.27% |
| 2019 Q1 | 37.36 Million EUR | 0.0% |
| 2018 FY | 29.05 Million EUR | -1.3% |
| 2017 Q1 | 29.44 Million EUR | 14.98% |
| 2017 FY | 29.44 Million EUR | 5.36% |
| 2017 Q4 | 32.53 Million EUR | 0.0% |
| 2017 Q3 | 32.53 Million EUR | 10.51% |
| 2017 Q2 | 29.44 Million EUR | -0.0% |
| 2016 FY | 27.94 Million EUR | -0.0% |
| 2016 Q4 | 25.6 Million EUR | 0.0% |
| 2016 Q1 | 27.94 Million EUR | 3.22% |
| 2016 Q2 | 27.94 Million EUR | 0.0% |
| 2016 Q3 | 25.6 Million EUR | -8.36% |
| 2015 FY | 27.94 Million EUR | -6.42% |
| 2015 Q2 | 27.94 Million EUR | 0.0% |
| 2015 Q1 | 27.94 Million EUR | -4.59% |
| 2015 Q4 | 27.07 Million EUR | 0.0% |
| 2015 Q3 | 27.07 Million EUR | -3.12% |
| 2014 Q4 | 29.28 Million EUR | 0.0% |
| 2014 FY | 29.86 Million EUR | -5.18% |
| 2014 Q2 | 29.86 Million EUR | 2.27% |
| 2014 Q1 | 29.19 Million EUR | 2.38% |
| 2014 Q3 | 29.28 Million EUR | -1.92% |
| 2013 Q2 | 31.49 Million EUR | 0.0% |
| 2013 Q3 | 28.51 Million EUR | -9.44% |
| 2013 Q4 | 28.51 Million EUR | 0.0% |
| 2013 Q1 | 31.49 Million EUR | -3.23% |
| 2013 FY | 31.49 Million EUR | -7.1% |
| 2012 Q1 | 33.9 Million EUR | -2.98% |
| 2012 Q4 | 32.54 Million EUR | 0.0% |
| 2012 Q3 | 32.54 Million EUR | -4.01% |
| 2012 Q2 | 33.9 Million EUR | 0.0% |
| 2012 FY | 33.9 Million EUR | -5.8% |
| 2011 Q3 | 34.94 Million EUR | -2.9% |
| 2011 FY | 35.98 Million EUR | -3.15% |
| 2011 Q4 | 34.94 Million EUR | 0.0% |
| 2011 Q2 | 35.98 Million EUR | 0.0% |
| 2010 Q2 | 37.15 Million EUR | 0.0% |
| 2010 Q4 | 32.5 Million EUR | 0.0% |
| 2010 FY | 37.15 Million EUR | 2.73% |
| 2009 FY | 36.16 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Affluent Medical SA | 25.15 Million EUR | 5.9% |
| Bluelinea Société Anonyme | 8.86 Million EUR | -166.981% |
| Carmat SA | 96.83 Million EUR | 75.558% |
| Diagnostic Medical Systems S.A. | 37.41 Million EUR | 36.746% |
| Eurobio Scientific Société anonyme | 141.15 Million EUR | 83.234% |
| Ikonisys S.A. | 5.11 Million EUR | -362.251% |
| Implanet S.A. | 10.81 Million EUR | -118.916% |
| Median Technologies SA | 46.22 Million EUR | 48.804% |
| SpineGuard SA | 5 Million EUR | -373.019% |
| Theraclion SA | 13.01 Million EUR | -81.822% |
| Euroapi S.A. | 684.7 Million EUR | 96.543% |
| Guerbet SA | 646.97 Million EUR | 96.342% |
| Ion Beam Applications SA | 490.44 Million EUR | 95.174% |
| Koninklijke Philips N.V. | 17.63 Billion EUR | 99.866% |
| Sequana Medical NV | 29.56 Million EUR | 19.952% |